New Research Sheds Light on Equitable Treatment Options for Pediatric Patients With Sickle Cell Disease
A new study led by Yale Cancer Center researchers at Yale School of Medicine for the first time analyzed the cost effectiveness of allotransplantation therapy and gene therapy to help determine equitable treatment options for this historically marginalized pediatric patient population in the United States.
How a Time Out Can Help Address Bias
To counter the sometimes-deadly effects of bias in healthcare, hospital executive Gina Calder, Dr. Cecelia Calhoun, and other leaders in the field developed a tool to help teams spot and address bias in real time. The Bias Time Out draws on a system that has successfully reduced other kinds of medical errors.Source: Yale Insights
Cancer Drug Shortage Eases Slightly, But it’s Still ‘Living from Paycheck to Paycheck’
The shortage of cancer drugs is not going away, but it may be easing slightly, a new national survey suggests. Based on questions posed to 29 of its 33 member hospitals, the National Comprehensive Cancer Network said Thursday that 86% of those cancer centers are experiencing a shortage of at least one type of generic chemotherapy drug, down from 90% in May. For pediatric cancers, the shortage of chemotherapy drugs hits even harder because newer treatments, such as immunotherapy, are not approved for children, Asher Marks, director of pediatric neuro-oncology at Yale Cancer Center, said in an interview. Carboplatin and cisplatin form the backbone of children’s treatment plans, so now that shortages seem to occur more frequently, pediatric oncologists have to fall back more often on methods they’ve used over the years.Source: STAT
They survived childhood cancer. But the disease has taken a toll on their mental health.
Nearly 16,000 children are diagnosed with cancer in the U.S. each year, according to the American Childhood Cancer Organization. Thanks to advances in treatment, survival rates in general are higher, but for survivors, there can be a hidden cost: their mental health.Source: Yahoo Life
Helping Young Adults with Sickle Cell Disease Navigate Healthcare Inequities
The Department of Internal Medicine’s August 10, 2023, grand rounds, “Understanding Transition in Sickle Cell Disease” was given by Cece Calhoun, MD, MPHS, MBA, assistant professor of medicine (hematology), Yale School of Medicine, and medical director of the Sickle Cell Program at Smilow Cancer Hospital and Yale Cancer Center.
Smilow Cancer Hospital Celebrates Opening of Dedicated Inpatient Sickle Cell Disease Clinic
We are proud to announce an extension of Smilow Cancer Hospital’s inpatient care to EP 4-7. Beginning on Tuesday, August 1, the 13-bed unit with telemetry will transition to the Smilow Service Line to accommodate patients with sickle cell disease (SCD) and additional hematology and oncology patients needing inpatient care.
Yale Center for Immersive Technologies in Pediatrics Is Announced
Building upon the successes of XR Pediatrics (XRPeds) within the department of Pediatrics at Yale School of Medicine, the new Center for Immersive Technologies in Pediatrics will grow beyond the lab by providing the Yale community at-large access to XR resources, support, expertise, and training.
Elite Reviewer Spotlight: Gary E. Friedlaender
The Elite Reviewers Program recognizes our best reviewers at The Journal of Bone & Joint Surgery for their outstanding efforts. All JBJS reviewers help maintain the highest standards for quality orthopaedic publishing. Today we introduce Elite Reviewer Gary E. Friedlaender.Source: The Journal of Bone & Joint Surgery
Study Identifies Bereaved Parents’ Medical Priorities for Children With Advanced Cancer
For families facing the end-of-life of a loved one with pediatric cancer, robust quality measures to benchmark what parents value most in their child’s medical care do not currently exist. A new study from Yale Cancer Center helps identify what parents prioritize for their children with advanced cancer, including alleviating the child’s symptoms and honoring the family’s goals and wishes. Researchers say the findings may help establish a patient-centered agenda for quality measurement and improvement in children with advanced, incurable cancer. The study titled, "Parent Priorities in End-of-Life Care for Children with Cancer,” was published in JAMA Network Open on May 15.
Connecticut Magazine’s 2023 “Top Doctors” issue recognizes 81 Smilow Cancer Hospital and Yale Cancer Center physicians
Each year, Connecticut Magazine recognizes some of the state’s best physicians, who provide exceptional care for patients, with its annual “Top Doctors” issue. This year’s list includes 82 physicians from Smilow Cancer Hospital and Yale Cancer Center, the only National Cancer Institute-designated comprehensive cancer center in the state.